期刊文献+

双氢青蒿素干预结直肠癌模型动物肿瘤生长的实验研究 被引量:8

Experimental Study on the Intervention of Dihydroartemisinin on Colorectal Cancer Growth in Animal Models
下载PDF
导出
摘要 【目的】观察双氢青蒿素(DHA)对结直肠癌模型动物肿瘤生长的影响。【方法】选用SPF级BALB/c裸鼠,背部皮下接种结直肠癌LoVo细胞悬液复制结直肠癌模型;造模成功裸鼠随机分成5组:模型对照组,5-FU组(腹腔注射5-FU20 mg.kg-1.d-1,共5 d),DHA高、中、低剂量组(分别按120、60、30 mg.kg-1.d-1剂量灌胃给药)。14 d后,检测活体肿瘤及解剖剥离后裸瘤体积、平均瘤体质量、肿瘤生长速率和抑瘤率。【结果】治疗后DHA各给药组及5-FU组活体肿瘤的体积及肿瘤生长速率均减少,与模型组比较差异有显著性意义(P<0.01);5-FU组及DHA高、中剂量组的裸瘤体积显著小于模型组(P<0.05或P<0.01);各给药组瘤体质量显著低于模型组(均P<0.05);DHA高、中剂量组的抑瘤率显著高于5-FU组(P<0.05),但DHA低剂量组抑癌率显著低于5-FU组(P<0.05)。【结论】DHA对结直肠癌模型动物肿瘤生长具有一定的抑制作用。 Objective To observe the influence of dihydroartemisinin(DHA) on colorectal cancer growth in animal models.Methods Colorectal cancer animal models were established by subcutaneous injection of colorectal cancer LoVo cells suspension into the back of specific-pathogen free BALB/c nude mice.Then the BALB/c tumor-bearing nude mice were randomized into 5 groups: model control group,5-FU group(intraperitoneal injection of 5-FU 20 mg·kg-1·d-1 for 5 days),and high-,middle-and low-dose DHA groups(gastric gavage of DHA in the dose of 120,60 and 30 mg·kg-1·d-1 respectively for 14 days).The in-vivo and in-vitro size of tumor mass,mean tumor mass weight,tumor growth rate and tumor-inhibition rate were examined after treatment.Results After treatment,the in-vivo size of tumor mass and the tumor growth rate were decreased in 5-FU group and DHA groups(P〈0.01 compared with those in the model group);in-vitro tumor mass size was reduced in 5-FU group and in high-and middle-dose DHA groups(P〈0.05 or P〈0.01);tumor mass weight in the medication groups was less than that in the model group(P〈0.05);the tumor-inhibition rate was higher in high-and middle-dose DHA groups but lower in low-dose DHA group than that in 5-FU group(P〈0.05).Conclusion DHA exerts certain inhibitory effect on tumor growth in colorectal cancer animal models.
出处 《广州中医药大学学报》 CAS 2009年第5期465-467,共3页 Journal of Guangzhou University of Traditional Chinese Medicine
关键词 双氢青蒿素/药理学 结肠肿瘤/中药疗法 直肠肿瘤/中药疗法 疾病模型 动物 裸鼠 DIHYDROARTEMISININ/pharmacology COLONIC NEOPLASMS /TCD therapy RECTAL NEOPLASMS/TCD therapy DISEASE MODELS ANIMAL NUDE MICE
  • 相关文献

参考文献6

  • 1Efferth T,Dunstan H,Sauerbrey A,et al.The anti-malarial artesunate is also active against cancer[J].International Journal of Oncelogy,2001,18 (4):767.
  • 2周从明,王小渝,吴康玉,张西.青蒿琥酯的抗肿瘤作用研究[J].四川肿瘤防治,2006,19(2):89-91. 被引量:8
  • 3Singh N P,Lai H.Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cencer cells[J].Life Sci,2001,70 (1):49.
  • 4李菌,周慧君.二氢青蒿素抑制K562细胞血管内皮生长因子的表达[J].药学学报,2005,40(11):1041-1045. 被引量:28
  • 5Chen H H,Zhou H J,Wu G D,et al.Inhibitory effects of artesuhate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1[J].Pharmacol,2004,71 (1):1.
  • 6吴细丕,钱林法.实验动物与肿瘤研究[M].北京:中国医药科技出版社,2006:116.

二级参考文献16

  • 1陈欢欢,周慧君.青蒿琥酯的抗血管生成作用[J].药学学报,2004,39(1):29-33. 被引量:20
  • 2杨小平,潘启超,梁永钜,张以琳.青蒿酯钠的抗肿瘤作用[J].癌症,1997,16(3):186-187. 被引量:57
  • 3Efferth T, Dunstan H, Sauerbrey A, et al. The anti-malarlal artesunate is also active against cancer [ J ]. International Journal of Oncology, 2001,18(4) :767-773.
  • 4Narendra P, Singh, Henry Lai. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cels [ J ].Life Seienees,2001,70 :49-56.
  • 5Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin[J]. Cancer Lett, 1995,91 ( 1 ) :41-46.
  • 6Reizenstein P. Iron, free radical and cancer [ J ]. Med Oncol Tumor Pharmacother 1991,8:229-233.
  • 7Wu Wenmin, Wu Yikang, Wu Yulin, et al. Unified Mechanistic Framework for the Fe(Ⅱ) -Induced Cleavage of Qinghaosu and Derivatives/Analogues. The First Spin-Trapping Evidence for the Previously Postulated Secondary C-4Radical [ J ]. J Am Chem See,1998,120:3316-3325.
  • 8Sadava D, Phillips T, Lin C, et al. Transferrin overcomes drug resistance to arternisinin in human small-cell lung carcinoma cells[J]. Cancer Lett, 2002,179 (2) : 151-156.
  • 9Reungpatthanaphong P, Mankhetkom S. Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLCA/adr resistant cell lines [ J ]. Biol Pharm Bull, 2002,25(12) :1555-1561.
  • 10Dell'Eva R, Pfeffer U, Vane R, et al. Inhibition of angiogenesis in vivo and growth of Kaposi' s sarcoma xenograft tumors by the anti-malarlal artesunate[J]. Biochem Pharmacol, 2004,68( 12):2359-2366.

共引文献33

同被引文献131

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部